FIELD: medicine.
SUBSTANCE: in blood from patient with extrasystole rate of Na+-Li+-countertransport in erythrocyte membrane is determined, and if its value is 38-203 mcM Li, anti-arrhythmia preparations of 3 classes: class1C: propafenone, class III amiodarone and class IV verapamil are introduced; if value is 204-271 mcM Li, anti-arrhythmia medication of class IC propaferone is introduced; if value is 272-345 mcM Li, anti-arrhythmia preparations of 2 classes are introduced: class II metoprolol and class III amiodarone; and if value is 346-730 mcM Li, anti-arrhythmia medication of class III amiodarone is introduced.
EFFECT: reduction of time for selection of anti-arrhythmia medications and elimination of possibility of development of proarrhythmogenic effect.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING ELECTRIC MYOCARDIAL INSTABILITY | 1998 |
|
RU2178983C2 |
| METHOD FOR PREDICTION OF DURATION OF PRESERVATION OF POSITIVE EFFECT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH EXTRASYSTOLIA | 2020 |
|
RU2749851C1 |
| METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS | 2019 |
|
RU2707261C1 |
| METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
| METHOD FOR SELECTION OF MOST EFFECTIVE ANTIARRHYTHMIC DRUG FOR PATIENTS WITH EXTRASISTOLY | 2017 |
|
RU2641164C1 |
| METHOD OF ASSAY OF INDIVIDUAL SENSITIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE TO ANTIANGINAL AND ANTIARRHYTHMIC PREPARATIONS IN LASEROTHERAPY CARRYING OUT | 1998 |
|
RU2141365C1 |
| METHOD FOR PREDICTING MECHANISMS OF VENTRICULAR EXTRASYSTOLIA | 2005 |
|
RU2294138C2 |
| METHOD FOR PREDICTION OF PROGRESSION OF VENTRICULAR ARRHYTHMIA IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS | 2014 |
|
RU2554808C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| METHOD FOR DETERMINING ELECTROPHYSIOLOGICAL MECHANISMS OF EXTRASYSTOLIA DEVELOPMENT | 1998 |
|
RU2214161C2 |
